Osaic Holdings
PCVX icon

Osaic Holdings’s Vaxcyte PCVX Stock Holding History

Osaic Holdings’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$467K Sell
8,028
-842
-9% -$45.7K ﹤0.01% 3729
2026
Q1 		$515K Buy
8,870
+5,429
+158% +$295K ﹤0.01% 3321
2025
Q4 		$159K Sell
3,441
-832
-19% -$37.2K ﹤0.01% 4330
2025
Q3 		$147K Buy
4,273
+414
+11% +$13.7K ﹤0.01% 4473
2025
Q2 		$128K Buy
3,859
+2,028
+111% +$66.5K ﹤0.01% 4295
2025
Q1 		$69.1K Buy
1,831
+191
+12% +$15.3K ﹤0.01% 4464
2024
Q4 		$73.9K Sell
1,640
-2,160
-57% -$214K ﹤0.01% 4405
2024
Q3 		$434K Buy
3,800
+3,474
+1,066% +$313K ﹤0.01% 3013
2024
Q2 		$24.6K Buy
326
+169
+108% +$11.5K ﹤0.01% 5191
2024
Q1 		$10.7K Sell
157
-3,599
-96% -$249K ﹤0.01% 5712
2023
Q4 		$236K Buy
3,756
+279
+8% +$14.5K ﹤0.01% 3781
2023
Q3 		$177K Sell
3,477
-596
-15% -$29.4K ﹤0.01% 4090
2023
Q2 		$200K Buy
4,073
+1,526
+60% +$72.3K ﹤0.01% 3893
2023
Q1 		$93.5K Sell
2,547
-1,776
-41% -$75.3K ﹤0.01% 4504
2022
Q4 		$206K Buy
4,323
+2,823
+188% +$111K ﹤0.01% 3817
2022
Q3 		$36K Hold
1,500
– – ﹤0.01% 5152
2022
Q2 		$33K Hold
1,500
– – ﹤0.01% 5263
2022
Q1 		$22K Sell
1,500
-500
-25% -$10.9K ﹤0.01% 5633
2021
Q4 		$53K Buy
+2,000
New +$46.5K ﹤0.01% 5108

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Osaic Holdings's PCVX Position: Q2 2026 in Review

Osaic Holdings reduced its Vaxcyte (PCVX) stake by 9.5% in Q2 2026, selling an estimated $45.7K and leaving 8,028 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #3729.

Osaic Holdings first reported a position in PCVX in Q4 2021 and has held it in 19 quarters since. The position peaked at $515K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Osaic Holdings held 8,028 shares of Vaxcyte worth $467K as of Q2 2026.
  • Osaic Holdings sold 842 Vaxcyte shares in Q2 2026, an estimated $45.7K.
  • Vaxcyte made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3729 holding.
  • Osaic Holdings first reported a position in Vaxcyte in Q4 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Vaxcyte position peaked at $515K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.